D.A. Davidson & Co.
- SEC CIK
- 0001080107
- Latest filing
- Jul 24, 2026
VKTX holding history
Viking Therapeutics, Inc. in every 13F filed by D.A. Davidson & Co., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
VKTX overviewAll 13F holders of VKTXFull Q2 2026 holdings
- Shares (Q1 2025)
- 0
- Sold out in Q1 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2025 | 0 | $0 | 0.0% | −7,480−100.0% | Sold out | Holders |
| Q4 2024 | 7,480 | $301.0K | <0.1% | +3,636+94.6% | Added | Holders |
| Q3 2024 | 3,844 | $243.4K | <0.1% | +3,844 | New | Holders |
| Q4 2021 | 0 | $0 | 0.0% | −12,500−100.0% | Sold out | Holders |
| Q3 2021 | 12,500 | $79.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2021 | 12,500 | $75.0K | <0.1% | +1,000+8.7% | Added | Holders |
| Q1 2021 | 11,500 | $73.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.